Oncobiologics Appoints CFO
This article was originally published in Scrip
Oncobiologics Inc. has appointed Lawrence Kenyon as its chief financial officer. Kenyon's most recent positions were at Arno Therapeutics Inc. (chief operating officer and CFO) and Tamir Biotechnology Inc. (interim president, chief executive officer and CFO).
Register for our free email digests: